Less Ads, More Data, More Tools Register for FREE

Pin to quick picksS & U Regulatory News (SUS)

Share Price Information for S & U (SUS)

Share Price is delayed by 15 minutes
Get Live Data
1,915.00    -10.00 (-0.52%)
Bid:
1,910.00
Ask:
1,945.00
Spread: 35.00 (1.832%)
Market Cap: £232.69m
SUS Live PriceLast checked at - London Stock Exchange

Intraday S & U Share Chart

Director/PDMR Shareholding

3 Oct 2011 16:32

RNS Number : 4584P
S & U PLC
03 October 2011
 



RNS Number :

S & U PLC

 



 

 

 

 

 

 

 

3 October 2011

 S & U PLC ("S&U" or "the Company")

 Director/PDMR Shareholding

S & U were advised today that Alexander Coombs, son of Anthony Coombs, Chairman of S&U Plc, has purchased 1,000 S&U Ordinary shares at a price of 640 pence per share.

Following this transaction, the beneficial shareholding of Anthony Coombs is 527,330 ordinary shares representing 4.5% of the total voting rights of the Company.

 For further information, please contact: 

 S&U plc www.suplc.co.uk 

Anthony Coombs, Chairman 0121 705 7777 

Broker and Financial Adviser

Adrian Trimmings/Jamie Cameron Arden Partners 0207 614 5920

 

Media and Investor Relations

Will Swan / Rebecca Whitehead Smithfield 020 7360 4900

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSEXLFBFBFLFBK
Date   Source Headline
20th May 20267:00 amRNSTrading Statement
13th May 20264:45 pmRNSAnnual Financial Report and Notice of AGM
8th May 20264:30 pmRNSDirector/PDMR Dealing
21st Apr 20267:00 amRNSPreliminary Results
13th Apr 20267:00 amRNSNotice of Results and Presentations
1st Apr 20267:00 amRNSFCA Redress Proposals
10th Feb 20267:00 amRNSTrading Statement and Notice of Results
11th Dec 20257:00 amRNSTrading Statement
17th Oct 20257:00 amRNSAppointment of Joint Broker
9th Oct 20257:00 amRNSInterim Results for the period ended 5 August 2025
6th Oct 20257:00 amRNSNotice of Investor Presentation
12th Aug 20257:00 amRNSTrading Update and Notice of Results
4th Aug 20257:00 amRNSSupreme Court motor finance ruling
8th Jul 20253:38 pmRNSDirector/PDMR Shareholding
18th Jun 20251:00 pmRNSResult of AGM
18th Jun 20257:00 amRNSAGM Statement and Trading Update
9th May 20254:45 pmRNSAnnual Report and Accounts and Notice of AGM
15th Apr 20257:00 amRNSPreliminary Results
7th Apr 20257:00 amRNSNotice of Results
11th Feb 20251:27 pmRNSAmendment to Trading Statement & Notice of Results
11th Feb 20257:00 amRNSTrading Update and Notice of Results
11th Dec 20247:00 amRNSTrading Statement
29th Oct 20242:00 pmRNSUpdate on Advantage Finance Limited
23rd Oct 20243:35 pmRNSDirector/PDMR and PCA Shareholding
23rd Oct 20242:00 pmRNSDirector/PDMR and PCA Shareholding
14th Oct 20247:00 amRNSUpdate on Advantage Finance Limited
8th Oct 20247:00 amRNSInterim Results for the 6 months to 31 July 2024
4th Oct 20247:00 amRNSNotice of Investor Presentation
19th Sep 20242:00 pmRNSTrading Update
12th Aug 20247:00 amRNSTrading Update and Notice of Results
6th Jun 20241:07 pmRNSResult of AGM
6th Jun 20247:00 amRNSAGM Statement and Trading Update
3rd May 20245:49 pmRNSDirector/PDMR and PCA Shareholding
3rd May 20242:00 pmRNSAnnual Report and Accounts
1st May 20244:19 pmRNSDirector/PDMR and PCA Shareholding
9th Apr 20247:00 amRNSPreliminary Unaudited FY Results to 31 Jan 24
25th Mar 20247:00 amRNSResults Presentations for Analysts and Investors
9th Feb 20247:00 amRNSTrading Statement and Notice of Results
1st Feb 20242:30 pmRNSNotice of Trading Update
11th Jan 20242:00 pmRNSDirector/PDMR Shareholding
12th Dec 20237:00 amRNSTrading Statement to 11 December 2023
31st Oct 20232:29 pmRNSDirector/PDMR and PCA Shareholding
5th Oct 20237:00 amRNSDirectorate Change
3rd Oct 20237:00 amRNSInterim Results for the 6 months to 31 July 2023
4th Sep 20237:00 amRNSNotice of Results and Investor Presentation
10th Aug 20237:00 amRNSTrading Update and Notice of Results
25th Jul 202311:34 amRNSDirector/PDMR Shareholding
17th Jul 20233:34 pmRNSDirector/PDMR Shareholding
26th May 20234:38 pmRNSDirector/PDMR Shareholding
25th May 202312:43 pmRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.